Article

Subscribe to EDC News

Subscribe to EDC News

External Link - article-514160.pdf

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!
Related Videos
Related Content
Credit: Lars Neumann | stock.adobe.com
August 7th 2025

FDA Supports Continued Development of Eftilagimod Alfa in PD-L1–Negative Head and Neck Cancer

Andy Studna, Senior Editor
ACT Brief Episode 1: Placebos, Politics, and the Ethics of Vaccine Trials
August 7th 2025

ACT Brief Episode 1: Placebos, Politics, and the Ethics of Vaccine Trials

Applied Clinical Trials Editorial Staff
MetaVia Expands GLP-1 Glucagon Receptor Agonist Obesity Trial Amid Signs of Superior Tolerability
August 7th 2025

MetaVia Expands GLP-1 Glucagon Receptor Agonist Obesity Trial Amid Signs of Superior Tolerability

Don Tracy, Associate Editor
Unifying Industry to Better Understand GCP Guidance
August 7th 2025

Unifying Industry to Better Understand GCP Guidance

Andy Studna, Senior Editor
Vertex’s Selective NaV1.8 Inhibitor Falls Short in Acute Pain Clinical Trial
August 7th 2025

Vertex’s Selective NaV1.8 Inhibitor Falls Short in Acute Pain Clinical Trial

Don Tracy, Associate Editor
Credit: Lisa | stock.adobe.com
August 7th 2025

FDA Grants Priority Review to Breyanzi for Relapsed Marginal Zone Lymphoma

Andy Studna, Senior Editor
© 2025 MJH Life Sciences

All rights reserved.